Jpmorgan Chase & CO Day One Biopharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 61,536 shares of DAWN stock, worth $392,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,536
Previous 60,427 1.84%
Holding current value
$392,599
Previous $765,000 36.34%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$7.93 - $13.21 $8,794 - $14,649
1,109 Added 1.84%
61,536 $487,000
Q4 2024

Feb 12, 2025
SELL
$12.46 - $16.39 $6,927 - $9,112
-556 Reduced 0.91%
60,427 $765,000
Q3 2024

Dec 26, 2024
BUY
$12.72 - $16.03 $6,741 - $8,495
530 Added 0.88%
60,983 $849,000
Q3 2024

Nov 08, 2024
BUY
$12.72 - $16.03 $6,741 - $8,495
530 Added 0.88%
60,983 $849,000
Q2 2024

Dec 26, 2024
SELL
$12.03 - $17.69 $6,375 - $9,375
-530 Reduced 0.87%
60,453 $833,000
Q2 2024

Aug 12, 2024
SELL
$12.03 - $17.69 $129,394 - $190,273
-10,756 Reduced 15.1%
60,453 $833,000
Q1 2024

Dec 26, 2024
BUY
$13.56 - $17.46 $138,664 - $178,545
10,226 Added 16.77%
71,209 $1.18 Million
Q1 2024

May 10, 2024
SELL
$13.56 - $17.46 $455,439 - $586,429
-33,587 Reduced 32.05%
71,209 $1.18 Million
Q4 2023

Dec 26, 2024
BUY
$9.68 - $15.37 $424,109 - $673,405
43,813 Added 71.84%
104,796 $1.53 Million
Q4 2023

Feb 12, 2024
BUY
$9.68 - $15.37 $128,453 - $203,959
13,270 Added 14.5%
104,796 $1.53 Million
Q3 2023

Nov 14, 2023
BUY
$11.22 - $14.86 $268,629 - $355,778
23,942 Added 35.43%
91,526 $1.12 Million
Q2 2023

Aug 11, 2023
BUY
$11.74 - $14.47 $532,679 - $656,547
45,373 Added 204.28%
67,584 $806,000
Q1 2023

May 18, 2023
BUY
$12.75 - $23.41 $270,440 - $496,549
21,211 Added 2121.1%
22,211 $296,000
Q1 2023

May 11, 2023
SELL
$12.75 - $23.41 $905,326 - $1.66 Million
-71,006 Reduced 98.61%
1,000 $13,000
Q4 2022

Feb 13, 2023
SELL
$18.77 - $22.0 $99,631 - $116,776
-5,308 Reduced 6.87%
72,006 $1.55 Million
Q3 2022

Nov 14, 2022
BUY
$16.44 - $26.57 $999,535 - $1.62 Million
60,799 Added 368.14%
77,314 $1.55 Million
Q2 2022

Aug 11, 2022
SELL
$5.72 - $17.9 $25,373 - $79,404
-4,436 Reduced 21.17%
16,515 $295,000
Q1 2022

May 11, 2022
SELL
$9.12 - $17.47 $282,802 - $541,727
-31,009 Reduced 59.68%
20,951 $208,000
Q4 2021

Feb 10, 2022
BUY
$15.65 - $26.33 $747,084 - $1.26 Million
47,737 Added 1130.4%
51,960 $875,000
Q3 2021

Nov 12, 2021
BUY
$20.0 - $27.92 $84,460 - $117,906
4,223 New
4,223 $100,000

Others Institutions Holding DAWN

# of Institutions
196
Shares Held
76.7M
Call Options Held
138K
Put Options Held
208K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $469M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email